Page last updated: 2024-08-18

4-butyrolactone and Giant Osteoid Osteoma

4-butyrolactone has been researched along with Giant Osteoid Osteoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cha, X; Hu, L; Li, B; Li, J; Liu, Y; Wu, D; Xie, B; Zhang, B; Zheng, L1

Other Studies

1 other study(ies) available for 4-butyrolactone and Giant Osteoid Osteoma

ArticleYear
Ligustilide inhibits the proliferation of human osteoblastoma MG63 cells through the TLR4-ERK pathway.
    Life sciences, 2022, Jan-01, Volume: 288

    Topics: 4-Butyrolactone; Apoptosis; Bone Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Osteoblastoma; Toll-Like Receptor 4; Tumor Cells, Cultured

2022